Milestone Pharmaceuticals Inc
NASDAQ:MIST
During the last 3 months Milestone Pharmaceuticals Inc insiders have not bought any shares, and sold 257k USD worth of shares. The stock price has dropped by 34% over this period (open performance analysis).
The last transaction was made on
Jan 26, 2026
by
Nelson Jeffrey Edward
, who
sold
23.6k USD
worth of 
MIST shares.
During the last 3 months Milestone Pharmaceuticals Inc insiders have not bought any shares, and sold 257k USD worth of shares. The stock price has dropped by 34% over this period (open performance analysis).
The last transaction was made on
Jan 26, 2026
by
Nelson Jeffrey Edward
, who
sold
23.6k USD
worth of MIST shares.
Milestone Pharmaceuticals Inc
Glance View
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. The company is headquartered in Montreal, Quebec and currently employs 29 full-time employees. The company went IPO on 2019-05-09. The firm is focused on the development and commercialization of cardiovascular medicines. Milestone’s lead product candidate is etripamil. The etripamil is a novel, potent and short-acting calcium channel blocker that has been designed rapid-onset nasal spray, which is self-administered by patients. The firm is developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF) and rapid ventricular rate, and other cardiovascular indications.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
